Posted: July 30, 2007 |
The story of a nanotechnology start-up |
(Nanowerk News) PharmaTelevision talks to Professor Tom Rademacher a professor at University College London (UCL)'s Immunology & Molecular Pathology Department, and President of Midatech, about the formation of the Midatech, Professor Rademacher’s fifth start-up company. Midatech is focused on exploring the possibilities of nanotechnology, particularly for medical therapeutic and diagnostic applications.
|
Specifically, the company is a manufacturer of biocompatible nanoparticles called nanocells. They possess a number of unique properties that make them ideal for therapeutics, diagnostics and other enabling applications.
|
He also talks in depth about the science behind the company's nanoparticle technology, as well as its applications in therapeutics, diagnostics and surface coatings.
|